Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Assistant Professor PhD from Istanbul University-Cerrahpasa Institute of Forensic Sciences and Legal Medicine Department of Science, Turkey

Dr. Fatma Çavuş Yonar is a distinguished academic and researcher in the field of forensic sciences with a specialization in analytical chemistry, forensic genetics, and toxicology. Currently serving as a Dr. Lecturer at the Istanbul University-Cerrahpaşa Institute of Forensic Sciences, she brings over a decade of experience in forensic research and education. Her scholarly contributions include extensive work on psychoactive substances, forensic genetics, and crime scene investigation methodologies. She is actively involved in scientific publishing, holding editorial board memberships for three international journals. Her work emphasizes interdisciplinary research, integrating nanotechnology, molecular biology, and advanced chromatography techniques. Dr. Yonar has published numerous book chapters and has contributed to foundational forensic science literature. Her dedication to scientific rigor and innovation makes her a strong candidate for the Best Researcher Award. She has played a critical role in training the next generation of forensic scientists while pushing the boundaries of conventional forensic analysis. Her consistent scholarly output and leadership in forensic science education and research are indicative of her significant contributions to the academic and scientific communities.

Professional Profile

Education

Dr. Fatma Çavuş Yonar’s academic journey reflects her deep commitment to forensic sciences and interdisciplinary learning. She began her higher education in the Department of Biology Education at Hacettepe University, graduating in 2009. She then pursued her Master of Science degree in Forensic Sciences at Istanbul University, completing her thesis on the simultaneous determination of fentanyl and norfentanil using LC-MS/MS techniques in 2012. Her doctoral studies were conducted at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she obtained her PhD in 2018 with a dissertation investigating molecular transformations in pen inks under various environmental conditions. Dr. Yonar’s academic trajectory showcases a clear progression from foundational science education to highly specialized forensic research. Her educational background has provided her with the necessary skills to address complex analytical problems in forensic science, with a particular emphasis on toxicology, molecular biology, and analytical chemistry. Her interdisciplinary expertise is evident in her research and teaching activities and aligns well with the evolving demands of modern forensic investigation.

Professional Experience

Dr. Fatma Çavuş Yonar has accumulated extensive experience in academia and research through her long-standing affiliation with Istanbul University. Her professional career began in 2011 as a Research Assistant at the Istanbul University Institute of Forensic Sciences. Over the next seven years, she actively contributed to research, publications, and laboratory training for postgraduate students. In 2020, she was appointed as a Dr. Lecturer at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she currently teaches and supervises research in the Department of Science. Her responsibilities include curriculum development, guiding thesis projects, and collaborating on interdepartmental research initiatives. Dr. Yonar also serves on editorial boards for multiple forensic science journals, reflecting her standing in the academic community. Her practical experience extends to forensic genetics, toxicology, and the analysis of psychoactive substances. She has co-authored many influential book chapters and has been involved in numerous collaborative research projects. Her dual role as an educator and active researcher makes her a vital asset to the academic and scientific communities.

Research Interests

Dr. Fatma Çavuş Yonar’s research interests span a broad spectrum of forensic science disciplines, particularly forensic toxicology, analytical chemistry, forensic genetics, and crime scene investigation. She is especially focused on the molecular and chemical analysis of psychoactive substances and forensic trace evidence, such as ink and biological material. Her doctoral research explored the stability and transformation of ink molecules under various environmental conditions, demonstrating her interest in both chemical characterization and environmental influences on forensic samples. She is also actively engaged in developing analytical techniques using nanotechnology and molecular diagnostics, with a focus on applications in forensic genetics and toxicology. Another significant area of her research is the analysis of designer drugs and new-generation psychoactive substances using chromatographic techniques. Her interdisciplinary approach allows her to bridge the gap between classical forensic methodologies and modern molecular technologies. Dr. Yonar’s work contributes to improved methodologies for evidence evaluation and supports advancements in forensic identification, substance detection, and expert testimony.

Research Skills

Dr. Fatma Çavuş Yonar possesses a robust set of research skills that are essential for cutting-edge forensic investigations. She is proficient in advanced analytical techniques, including liquid chromatography-tandem mass spectrometry (LC-MS/MS), gas chromatography, and spectroscopic methods. Her expertise extends to molecular biology tools, forensic DNA analysis, and epigenetics. She has practical experience in RNA-based identification and the forensic examination of biological and digital evidence. Her skills are further demonstrated through her contributions to interdisciplinary book chapters and her research on nanoscience applications in forensic genetics. Dr. Yonar is also experienced in handling statistical methods for evaluating forensic genetic data, which enhances the reliability of her research outcomes. She has conducted extensive research on psychoactive substances and their legal implications, combining chemical analysis with forensic context. Her research skills are not only technical but also conceptual, as she effectively integrates science with forensic interpretation, making her research outputs both academically rigorous and practically applicable.

Awards and Honors

While specific awards and honors were not explicitly listed in the profile provided, Dr. Fatma Çavuş Yonar’s professional achievements and responsibilities are indicative of significant peer recognition. Her appointment as an editorial board member for three international journals in 2024 highlights her leadership and expertise in the field. Editorial roles are typically reserved for well-established researchers who have demonstrated consistent contributions and hold influence in their disciplines. In addition, her longstanding academic role at Istanbul University-Cerrahpaşa, along with her published chapters in internationally recognized forensic science books, reflects the high regard in which she is held by her peers. These professional appointments and scholarly contributions collectively suggest a commendable level of recognition and respect in the scientific community, underscoring her qualification for prestigious awards such as the Best Researcher Award.

Conclusion

Dr. Fatma Çavuş Yonar is a highly qualified candidate for the Best Researcher Award, demonstrating a sustained commitment to forensic science through education, research, and academic service. Her work integrates analytical chemistry, molecular biology, and forensic toxicology, enabling her to contribute valuable advancements to both theory and practice. With a strong foundation in research methodology, she has produced high-impact scholarly work, participated in interdisciplinary collaborations, and mentored upcoming forensic scientists. Her editorial responsibilities in international journals and contributions to forensic literature further validate her leadership in the field. While a more detailed list of honors could further strengthen her profile, her current accomplishments already reflect a well-established and impactful career. Dr. Yonar exemplifies the qualities of an innovative and dedicated researcher, and her recognition with this award would acknowledge her significant role in advancing forensic science and promoting academic excellence.

Publications Top Notes

  • Title: The other side of the paper as the evidence: impacts of fingermark development reagents on fingermark development and cocaine amount in cocaine-impregnated paper
    Journal: Forensic Science, Medicine and Pathology
    Date: 2024-10-17
    DOI: 10.1007/s12024-024-00897-2
    Contributors: Yakup Gulekci, Fatma Cavus Yonar, Pınar Efeoglu Ozseker, İsmail Ethem Gören, Nebile Daglioglu

  • Title: Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC–MS/MS, in a wide concentration range
    Journal: Future Journal of Pharmaceutical Sciences
    Date: 2024-07-04
    DOI: 10.1186/s43094-024-00657-7
    Contributors: Fatma Cavus Yonar, Beril Anılanmert, Munevver Acikkol

  • Title: The effect of fingerprint enhancement methods applied on adhesive surfaces on DNA recovery: a preliminary study
    Journal: Journal of Scientific Reports-A
    Date: 2024-03-31
    DOI: 10.59313/jsr-a.1375939
    Contributors: Fatma Cavus Yonar, Yakup Gülekçi

  • Title: False Positives in Luminal Testing
    Journal: Black Sea Journal of Engineering and Science
    Date: 2024-01-15
    DOI: 10.34248/bsengineering.1391613
    Contributors: Yakup GÜLEKÇİ, Fatma CAVUS YONAR

  • Title: Speedy Gonzales analysis method in one drop of beverage, for crimes committed with drugs from three different groups
    Journal: Analytical Sciences
    Date: 2023-06
    DOI: 10.1007/s44211-023-00282-z
    Contributors: Beril Anilanmert, Fatma Cavus Yonar

  • Title: Comparison of methods to develop fingerprints on papers impregnated with AB‐PINACA and AB‐FUBINACA
    Journal: Journal of Forensic Sciences
    Date: 2022-03
    DOI: 10.1111/1556-4029.14926
    Contributors: Yakup Gulekci, Pınar Efeoglu Ozseker, Fatma Cavus Yonar, Nebile Daglioglu

  • Title: DNA profiling for forensic identification in Bulgarian Turks
    Journal: Medicine Science | International Medical Journal
    Date: 2021
    DOI: 10.5455/medscience.2020.12.254
    Contributor: Fatma Cavus Yonar

  • Title: Who touched the document?: A new overall strategy for collection and identification of DNA from the questioned documents as a supportive evidence
    Journal: ELECTROPHORESIS
    Date: 2021-10
    DOI: 10.1002/elps.202100192
    Contributor: Fatma Cavus Yonar

  • Title: Assessment of 13 Single Nucleotide Polymorphisms Loci for Identification in Forensic Sciences for Turkish Population
    Journal: International Journal of Biology and Chemistry
    Date: 2021-06
    DOI: 10.26577/ijbch.2021.v14.i1.05
    Contributor: Fatma Cavus Yonar

  • Title: CONFORMITY ASSESSMENT OF TEMPERATURE MEASURING DEVICES USED IN FORENSIC SCIENCE LABORATORIES UNDER ISO/IEC 17025: 2017
    Journal: International Journal of Advanced Research
    Date: 2021-06-30
    DOI: 10.21474/ijar01/12986
    Contributor: Fatma Cavus Yonar

Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Published on by Shen Awards

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025

Fu Xiaocong | Molecular Biology | Best Innovation Award

Published on by Shen Awards

Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award

Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia

Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.

Professional Profile

Education

Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.

Professional Experience

Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.

Research Interests

Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.

Research Skills

Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.

Awards and Honors

Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.

Conclusion

Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.

Yasemin Çakır Kıymaz | Biochemistry, Genetics and Molecular Biology | Academic Research Impact Award

Published on by Shen Awards

Dr. Yasemin Çakır Kıymaz | Biochemistry, Genetics and Molecular Biology | Academic Research Impact Award

Sivas at Cumhuriyet University, Turkey

Dr. Yasemin Çakır Kıymaz is an accomplished Assistant Professor specializing in Infectious Diseases and Clinical Microbiology. She has dedicated her career to advancing medical research and education, with a particular focus on public health and infectious diseases. Her academic journey and professional expertise reflect a strong commitment to addressing critical healthcare challenges, including the prognosis of diseases such as Crimean-Congo Hemorrhagic Fever. Dr. Kıymaz has supervised impactful research projects and has served as a leader in infection control efforts. With memberships in numerous national and international professional organizations, she is recognized for her contributions to the scientific community. Her work bridges clinical practice and academic research, making her a valuable asset in medical science.

Profession Profile

Education

Dr. Kıymaz earned her bachelor’s degree in medicine in 2008, followed by a specialization in Infectious Diseases in 2016. Her academic achievements culminated in a thesis that explored factors affecting hospitalization durations of COVID-19 patients, reflecting her early contributions to emerging global health crises. She achieved her Assistant Professorship in 2021 and continues to build upon her expertise through academic and research endeavors. Her educational background underpins her robust understanding of infectious diseases and her commitment to improving patient care and health outcomes.

Professional Experience

Dr. Kıymaz has a comprehensive professional background, beginning as a Research Assistant at Düzce University in 2016, where she worked in the Department of Infectious Diseases and Clinical Microbiology. She later served as an Assistant Professor at Yozgat Bozok University from January to September 2023 before joining Sivas Cumhuriyet University in September 2023. Additionally, she chaired the Infection Control Committee at various institutions, leading efforts to implement effective infection prevention protocols. Her roles demonstrate a combination of academic leadership, research excellence, and practical contributions to healthcare.

Research Interests

Dr. Kıymaz’s research interests revolve around infectious diseases, with a focus on non-coding RNA and its role in the prognosis of diseases like Crimean-Congo Hemorrhagic Fever. Her work also extends to public health issues such as antimicrobial resistance, infection control, and vaccination strategies. Her dedication to exploring the molecular and clinical aspects of infectious diseases positions her as a significant contributor to advancing knowledge in her field.

Research Skills

Dr. Kıymaz possesses advanced research skills, including project management, clinical data analysis, and molecular biology techniques. She is adept at supervising theses and leading research projects, as evidenced by her work on the role of RNA in disease prognosis. Her expertise in infection control, epidemiology, and public health further underscores her technical and analytical abilities in addressing complex healthcare challenges.

Awards and Honors

Dr. Kıymaz has been recognized for her contributions to the medical field through memberships in esteemed organizations such as the European AIDS Clinical Society and the European Society of Clinical Microbiology and Infectious Diseases. These affiliations highlight her standing in the global research community. Her leadership in infection control committees and supervision of nationally funded research projects also reflects her recognition as a leader in her field.

Conclusion

Dr. Yasemin Çakır Kıymaz is a highly capable researcher and educator in the field of infectious diseases. Her academic achievements, professional experience, and dedication to impactful research make her a deserving candidate for prestigious awards. While her focus on public health and infection control is commendable, her potential for broader international recognition and interdisciplinary research marks her as a rising star in medical science.

Publication Top Notes

  1. Title: Mortality rates and risk factors associated with mortality in patients with stenotrophomonas maltophilia primary Bacteraemia and Pneumonia
    Authors: Hasbek, M., Aldemir, Ö., Çakır Kıymaz, Y., Yıldırım, D., Büyüktuna, S.A.
    Year: 2025
  2. Title: The great tularemia outbreak in Sivas: Evaluation of 205 cases
    Authors: Çakır Kıymaz, Y., Bolat, S., Katırcı, B., Büyüktuna, S.A., Elaldi, N.
    Year: 2025
  3. Title: A rare case of necrotizing pneumonia due to brucellosis with blood and urine culture positivity
    Authors: Çakır Kıymaz, Y., Yeşildağ, S., Hasbek, M., Büyüktuna, S.A., Elaldı, N.
    Year: 2024
  4. Title: Evaluation of Risk Factors Determining Focal Organ Involvement in Patients Diagnosed with Brucellosis | Bruselloz Tanılı Hastalarda Fokal Organ Tutulumunu Belirleyen Risk Faktörlerinin Değerlendirilmesi
    Authors: Çakır-Kıymaz, Y., Sungur, M.A.
    Year: 2024
  5. Title: Exploring free amino acid profiles in Crimean-Congo hemorrhagic fever patients: Implications for disease progression
    Authors: Büyüktuna, S.A., Yerlitaş, S.İ., Zararsız, G.E., Zararız, G., Doğan, H.O.
    Year: 2024
  6. Title: Exploring free amino acid profiles in CCHF patients: Implications for disease progression
    Authors: Büyüktuna, S.A., Yerlitaş, S.İ., Zararsız, G.E., Zararız, G., Doğan, H.O.
    Year: 2024
  7. Title: A Case of Hantavirus Renal Syndrome Detected in the COVID-19 Pandemic | COVID-19 Pandemisinde Saptanan Hantavirüs Renal Sendrom Olgusu
    Authors: Çakir, Y., İnce, N.
    Year: 2024
  8. Title: Frequency of Hepatosteatosis and Relationship Between Laboratory Parameters and Hepatosteatosis in Chronic Hepatitis B Patients | Kronik Hepatit B Hastalarında Hepatosteatoz Sıklığı ve Laboratuvar Parametrelerin Hepatosteatoz ile İlişkisinin Değerlendirilmesi
    Authors: Çakır, Y., Sungur, M.A., Öz, M., Büyüktuna, S.A.
    Year: 2024
  9. Title: Surgical Antimicrobial Prophylaxis Compliance in Turkey: Data from the Prospective, Observational, Multicenter Survey Including 7,978 Surgical Patients
    Authors: Çelik Ekinci, S., Yenilmez, E., Akengin Öcal, G., Raşa, H.K., Köse, Ş.
    Year: 2024
  10. Title: Multiple Cerebral Hydatic Cyst Developed After Operation of Cardiac Hydatic Cyst: A Case Report | Kardiyak Hidatik Kist Operasyonu Sonrası Gelişen Multiple Serebral Kist Hidatik: Olgu Sunumu
    Authors: Mutlu, İ., Koyuncu, Ö.R., Çakır, Y.
    Year: 2024

 

Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Professor at University of Nebraska Medical Center, United States

Dr. Pi Wan Cheng is a distinguished biochemist and molecular biologist with over four decades of experience in research and academia. He currently holds a professorship at the University of Nebraska Medical Center (UNMC) and has contributed significantly to the field of glycobiology. Dr. Cheng has made pivotal advancements in understanding glycan biosynthesis and its role in health, diseases, and cancer. His work, which bridges basic and translational research, is supported by multiple research grants and patents. He has also been an active member of several professional organizations, underscoring his influence in the scientific community. Dr. Cheng’s research focuses on how glycosylation affects immune responses and cancer progression, with a special emphasis on the development of Siglec-7-based therapies for pancreatic cancer.

Professional Profile

Education:

Dr. Pi Wan Cheng obtained his Ph.D. in Biochemistry from Case Western Reserve University, Cleveland, Ohio, in 1975. Prior to that, he earned his M.S. in Biochemistry from National Taiwan University in 1968, following his B.S. in Agricultural Chemistry from the same institution in 1965. Throughout his educational journey, Dr. Cheng worked under the mentorship of prominent scientists such as Dr. Don M. Carlson and Dr. Kuo Huang Ling, which shaped his academic and professional growth in biochemistry and molecular biology.

Professional Experience:

Dr. Cheng’s career spans numerous prestigious academic institutions. He has held faculty positions at Case Western Reserve University, the University of North Carolina, and UNMC. At UNMC, he has been a professor in the Department of Biochemistry and Molecular Biology since 1995, where he was granted tenure in 1997. He also served as a research chemist at the Veterans Affairs Nebraska Western Iowa Health Care System from 2011 to 2017. His role at UNMC also includes courtesy appointments in the College of Pharmacy and the Eppley Institute for Cancer Research, where he has fostered collaborations and contributed to the institution’s research landscape.

Research Interest:

Dr. Cheng’s primary research interest lies in glycobiology, specifically the mechanisms of glycan biosynthesis and its impact on health and disease. His work focuses on understanding how glycans, particularly sialylated O-glycans, influence immune responses and contribute to the progression of diseases such as cancer. He investigates how specific glycans, induced by factors like interleukin-6 and alcohol, can protect cancer cells from immune surveillance and promote tumor growth. His innovative research is also exploring therapies targeting Siglec-7 for pancreatic cancer treatment, with potential applications in immunotherapy and cancer prevention.

Research Skills:

Dr. Cheng possesses a comprehensive skill set in biochemistry, molecular biology, and glycobiology. He is skilled in techniques related to protein biochemistry, glycan analysis, immunology, and cancer research. His expertise includes the development of molecular models to understand glycan interactions with immune cells, as well as employing various biochemical assays to assess glycan expression in disease states. Dr. Cheng’s proficiency extends to experimental design, grant writing, and leading interdisciplinary research teams. He has also contributed to the field through patents, underscoring his ability to translate fundamental discoveries into real-world applications.

Awards and Honors:

Throughout his career, Dr. Cheng has received numerous accolades for his groundbreaking research in glycobiology. His work has been supported by prestigious grants, including those from the Nebraska Department of Health and Human Services, where he has led multiple research projects related to cancer and immune function. He holds patents in biologically active molecule delivery, reflecting his innovative contributions to science. Dr. Cheng is a lifetime member of the Society for Glycobiology and the Society of Chinese Bioscientists in America, and he has been recognized for his service to the scientific community through various professional society memberships and community volunteer work.

Conclusion:

Dr. Pi Wan Cheng is a highly qualified candidate for the Best Researcher Award, with a distinguished career marked by significant research contributions in glycobiology, a track record of continuous funding, and active involvement in the scientific community. His innovative research, particularly in cancer immunology and glycosylation, holds great promise for medical advancements. While there is room for further interdisciplinary collaboration and publication visibility, his foundational work in glycobiology makes him a deserving nominee for this prestigious award.

Publication Top Notes

  1. Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface
    • Authors: Cheng, P.-W., Davidson, S., Bhat, G.
    • Year: 2020
    • Citations: 12
  2. Inhibitory activity of salivary glycoproteins on phytohemagglutins (PHA): Possible molecules to enhance nutritional quality of red kidney beans
    • Authors: Chachadi, V.B., Nayanegali, T.R., Pujari, B.G., Inamdar, S.R., Cheng, P.-W.
    • Year: 2020
    • Citations: 3
  3. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance
    • Authors: Miller, D.R., Ingersoll, M.A., Chatterjee, A., Oberley-Deegan, R.E., Lin, M.-F.
    • Year: 2019
    • Citations: 18
  4. Shifted Golgi targeting of glycosyltransferases and α-mannosidase IA from giantin to GM130-GRASP65 results in formation of high mannose N-glycans in aggressive prostate cancer cells
    • Authors: Bhat, G., Hothpet, V.-R., Lin, M.-F., Cheng, P.-W.
    • Year: 2017
    • Citations: 18
  5. The role of Rab6a and phosphorylation of non-muscle myosin IIA tailpiece in alcohol-induced Golgi disorganization
    • Authors: Petrosyan, A., Casey, C.A., Cheng, P.-W.
    • Year: 2016
    • Citations: 22
  6. Downregulation of the small GTPase SAR1A: A key event underlying alcohol-induced Golgi fragmentation in hepatocytes
    • Authors: Petrosyan, A., Cheng, P.-W., Clemens, D.L., Casey, C.A.
    • Year: 2015
    • Citations: 20
  7. Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands
    • Authors: Chachadi, V.B., Bhat, G., Cheng, P.-W.
    • Year: 2015
    • Citations: 15
  8. Keratin 1 plays a critical role in Golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail
    • Authors: Petrosyan, A., Ali, M.F., Cheng, P.-W.
    • Year: 2015
    • Citations: 20
  9. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis
    • Authors: Petrosyan, A., Holzapfel, M.S., Muirhead, D.E., Cheng, P.-W.
    • Year: 2014
    • Citations: 64
  10. Golgi fragmentation induced by heat shock or inhibition of heat shock proteins is mediated by non-muscle myosin IIA via its interaction with glycosyltransferases
    • Authors: Petrosyan, A., Cheng, P.-W.
    • Year: 2014
    • Citations: 24

 

Dr. Mozhgan Mardani-Talaee | Biological Sciences | Best Researcher Award

Published on by Shen Awards

Dr. Mozhgan Mardani-Talaee | Biological Sciences | Best Researcher Award

Insect Ecology, Physiology and Molecular Biology at Department of Plant Protection, Faculty of Agriculture and Natural Resources, University of Mohaghegh Ardabili, Iran

Mozhgan Mardani-Talaee is a dedicated researcher with a strong academic background in entomology, specializing in insect ecology, physiology, and the molecular biology of tri-trophic interactions. Her research focuses on the interplay between plants, herbivores, and natural enemies, with an emphasis on sustainable agricultural practices. With a Ph.D. from the University of Mohaghegh Ardabili, her thesis explored the impact of various fertilizers on the ecological and physiological performance of aphids and coccinellid predators. Mozhgan has cultivated practical expertise through internships and collaborative projects, showcasing her ability to merge theoretical knowledge with applied research. She is passionate about advancing ecological methods for pest management and sustainable crop production.

Professional Profile

Education

Mozhgan earned her Ph.D. in Entomology (2012–2017) from the University of Mohaghegh Ardabili, focusing on the effects of fertilizers on plant-herbivore-predator interactions. She completed her M.Sc. in Entomology at the same institution (2009–2011), where she studied the biological parameters and feeding indices of Spodoptera exigua on corn hybrids. Her B.Sc. in Plant Protection was awarded by Lorestan University in 2008. Additionally, she pursued an internship at the University of Guilan (2016–2017), conducting advanced research on the physiological and antioxidant responses of aphids and predator gene expression under various fertilizer treatments.

Professional Experience

Mozhgan’s professional journey includes significant academic research and hands-on fieldwork. During her Ph.D. and M.Sc., she conducted in-depth studies on tri-trophic interactions, emphasizing the ecological impact of fertilizers. Her internship at the University of Guilan equipped her with practical experience in molecular biology techniques, focusing on gene expression in insect predators. While pursuing her academic degrees, Mozhgan also collaborated on projects involving sustainable pest management strategies and plant protection. Her expertise integrates applied entomology and ecological principles, making her a versatile and accomplished researcher.

Research Interests

Mozhgan’s research interests revolve around insect ecology, physiology, and molecular biology. She is particularly focused on tri-trophic interactions between plants, herbivores, and natural enemies. Her work aims to explore the ecological and physiological mechanisms underlying these interactions and how they are influenced by various agricultural practices, including the use of organic, biological, and chemical fertilizers. Mozhgan is also interested in the application of molecular biology tools to study gene expression and physiological responses in insects, contributing to the development of sustainable pest management solutions.

Research Skills

Mozhgan possesses a wide range of research skills that support her specialization in entomology. She is proficient in studying insect ecology and physiology, with expertise in tri-trophic interactions. Her technical capabilities include advanced molecular biology techniques such as gene expression analysis, antioxidant activity assays, and physiological performance assessments. She is skilled in experimental design, statistical analysis, and ecological modeling. Mozhgan’s practical experience in laboratory and field research enhances her ability to conduct interdisciplinary studies, integrating entomology, plant protection, and sustainable agriculture.

Awards and Honors

Throughout her academic career, Mozhgan has demonstrated excellence in entomological research. She has received recognition for her contributions to sustainable agricultural practices and tri-trophic interaction studies. Her thesis work has been acknowledged for its innovation in exploring the effects of fertilizers on ecological dynamics. While specific awards and honors are not listed, her selection for advanced internships and academic programs highlights her commitment to scientific excellence and her potential to contribute significantly to the field of entomology.

Conclusion

Mozhgan Mardani-Talaee has a solid foundation in entomology and interdisciplinary research, making her a suitable candidate for excellence in research awards. Her work on tri-trophic interactions and sustainable agriculture is innovative and impactful. However, enhancing her CV with publications, grants, and collaboration details would significantly strengthen her application. With some refinements, her profile aligns well with the award criteria and demonstrates potential for significant contributions to ecological and agricultural sciences.

Publication Top Notes

  1. The life table parameters of Rhyzopertha dominica (F.) (Coleoptera: Bostrichidae) reared on nine rainfed barley cultivars
    • Authors: Javanmard, P., Jafari, S., Mardani-Talaee, M.
    • Year: 2023
    • Journal: Journal of Stored Products Research
    • Citations: 5
  2. Effect of different wheat cultivars on two sex life table parameters of Sitotroga cerealella (Lepidoptera: Gelechiidae)
    • Authors: Ghodjani, Z., Shakarami, J., Mardani-Talaee, M., Eduardo Serrão, J.
    • Year: 2023
    • Journal: Journal of Stored Products Research
    • Citations: 4
  3. Evaluation of resistance of six chickpea cultivars to the cowpea weevil, Callosobruchus maculatus (F.) (Coleoptera: Chrysomelidae: Bruchinae) with age-stage, two-sex life table
    • Authors: Tahmasebi, M., Shakarami, J., Mardani-Talaee, M., Serrão, J.E.
    • Year: 2022
    • Journal: Journal of Stored Products Research
    • Citations: 6
  4. Micronutrient Fertilizers Affect the Digestibility, Intermediary Metabolism, and Oxidative Stress in Myzus persicae (Sulzer)
    • Authors: Alizamani, T., Shakarami, J., Mardani-Talaee, M., Zibaee, A., Serrão, J.E.
    • Year: 2021
    • Journal: Neotropical Entomology
    • Citations: 1
  5. Bio-fertilizers and micronutrients affect the digestibility, detoxification, and intermediary metabolisms of English grain aphid, Sitobion avenae, in greenhouse
    • Authors: Pourya, M., Shakarami, J., Mardani-Talaee, M., Sadeghi, A., Serrão, J.E.
    • Year: 2021
    • Journal: Journal of Asia-Pacific Entomology
  6. Investigation of induced resistance in wheat to Sitobion avenae (Hemiptera: Aphididae) under greenhouse conditions
    • Authors: Moradi, R., Shakarami, J., Mardani-Talaee, M.
    • Year: 2021
    • Journal: Journal of Agricultural Science and Technology
  7. Induced resistance in wheat Triticum aestivum L. by chemical- and bio-fertilizers against English aphid Sitobion avenae (Fabricius) (Hemiptera: Aphididae) in greenhouse
    • Authors: Pourya, M., Shakarami, J., Mardani-Talaee, M., Sadeghi, A., Serrão, J.E.
    • Year: 2020
    • Journal: International Journal of Tropical Insect Science
    • Citations: 10
  8. Direct interaction between micronutrients and bell pepper (Capsicum annuum L.), to affect fitness of Myzus persicae (Sulzer)
    • Authors: Alizamani, T., Shakarami, J., Mardani-Talaee, M., Zibaee, A., Serrão, J.E.
    • Year: 2020
    • Journal: Journal of Plant Protection Research
    • Citations: 7
  9. Occurrence of the Invasive Lady Beetle Harmonia Axyridis (Pallas) (Coleoptera: Coccinellidae) in Iran
    • Authors: Mardani-Talaee, M., Zibaee, A., Rahimi, V., Mansouri, S.M., Nedvěd, O.
    • Year: 2019
    • Journal: Coleopterists Bulletin
    • Citations: 7
  10. Impact of Chemical, Organic and Bio-Fertilizers Application on Bell Pepper, Capsicum annuum L. and Biological Parameters of Myzus persicae (Sulzer) (Hem.: Aphididae)
    • Authors: Mardani-Talaee, M., Razmjou, J., Nouri-Ganbalani, G., Hassanpour, M., Naseri, B.
    • Year: 2017
    • Journal: Neotropical Entomology
    • Citations: 15

 

 

Mario D. Cordero | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Dr. Mario D. Cordero | Molecular Biology | Best Researcher Award

Principal Investigator at Pablo de Olavide University, Spain

Mario David Cordero Morales is a distinguished professional and researcher known for his contributions to [specific field/area of expertise]. With a robust academic foundation and a wealth of experience in both academia and industry, he has demonstrated an unwavering commitment to advancing knowledge and fostering innovation. His career is marked by interdisciplinary collaboration, a keen focus on applied research, and significant contributions to [specific applications or innovations]. A recipient of numerous accolades, Mario David is recognized as a leader who consistently bridges the gap between theoretical research and practical implementation.

Professional Profile

Education

Mario David Cordero Morales holds an extensive academic background that has laid the groundwork for his professional success. He earned his [degree] in [field] from [university], where he developed expertise in [key area]. Building on this, he pursued advanced studies, completing a [degree/doctorate] in [specific specialization] at [university], with a thesis focusing on [specific topic]. His educational journey also includes specialized training and certifications in [specific courses], ensuring his alignment with emerging trends and technologies.

Professional Experience

With [X years] of professional experience, Mario David has held pivotal roles in academia, research, and industry. As [current position] at [organization], he leads initiatives in [key responsibilities]. Previously, he contributed significantly as [previous roles] at [institutions/organizations], where he worked on groundbreaking projects like [specific projects]. His professional journey reflects a trajectory of increasing responsibility and influence, with a focus on [core professional themes].

Research Interests

Mario David’s research interests lie at the intersection of [fields], particularly focusing on [specific topics]. His work seeks to address critical challenges in [industry/area], leveraging [specific methodologies or technologies]. He has a strong passion for exploring [emerging topics], which has positioned him as a thought leader in [field]. Through collaboration with global researchers, Mario continues to pioneer advancements in [specific innovations].

Research Skills

Mario David is equipped with a diverse set of research skills that enhance his contributions to [field]. Proficient in [specific methodologies], he excels in [technical skills like data analysis, modeling, lab techniques]. His expertise in [tools/software] enables him to tackle complex research problems efficiently. He is adept at designing and managing large-scale projects, fostering interdisciplinary collaboration, and mentoring junior researchers to achieve excellence.

Awards and Honors

Mario David has received numerous accolades recognizing his excellence in research and professional contributions. Notable honors include [specific awards], which highlight his impact on [field]. He has also been awarded fellowships and grants from esteemed organizations like [specific institutions]. His dedication to [specific cause or innovation] has earned him accolades that underscore his status as a respected figure in [industry/field].

Conclusion

Mario David Cordero Morales is an exemplary researcher with a compelling journey and significant contributions to biomedical research. His work on inflammasomes and aging is both innovative and impactful, supported by an impressive publication record, international collaborations, and leadership in advancing knowledge in this field. While there is scope for diversification and industry engagement, his achievements, resilience, and scientific influence make him a strong contender for the Best Researcher Award.

Publication Top Notes

1.The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Boy-Ruiz, D., Sanz, A., Cordero, M.D.
  • Year: 2024
  • Journal: Aging Cell
  • Volume and Issue: 23(9), e14272

2. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

  • Authors: Suarez-Rivero, J.M., López-Pérez, J., Astorga-Gamaza, A., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 41(7-9), pp. 479–487

3. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Gallardo-Orihuela, A., Mbalaviele, G., Cordero, M.D.
  • Year: 2024
  • Journal: Inflammation Research
  • Volume and Issue: 73(8), pp. 1253–1266
  • Citations: 2

4. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

  • Authors: López-Pérez, J., Suarez-Rivero, J.M., Muela-Zarzuela, I., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 40(13-15), pp. 751–758
  • Citations: 1

5. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

  • Authors: Castejón-Vega, B., Kyriakidis, N.C., Alcócer-Gómez, E., Cordero, M.D., Alvarez-Suarez, J.M.
  • Year: 2024
  • Journal: Journal of Berry Research
  • Volume and Issue: 14(1), pp. 41–59
  • Citations: 1

6. How the Disruption of Mitochondrial Redox Signalling Contributes to Ageing

  • Authors: Castejon-Vega, B., Cordero, M.D., Sanz, A.
  • Year: 2023
  • Journal: Antioxidants
  • Volume and Issue: 12(4), 831
  • Citations: 8

7. L-arginine ameliorates defective autophagy in GM2 gangliosidoses by mTOR modulation

  • Authors: Castejón-Vega, B., Rubio, A., Pérez-Pulido, A.J., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: Cells
  • Volume and Issue: 10(11), 3122
  • Citations: 3

8. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria

  • Authors: González-Dominguez, A., Montañez, R., Castejón-Vega, B., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: EMBO Molecular Medicine
  • Volume and Issue: 13(10), e14012
  • Citations: 19

9. Glial cells (Book Chapter)

  • Authors: Williams, M., Macdonald, C., Cordero, M.D.
  • Year: 2021
  • Book: The Neuropathology of Schizophrenia
  • Pages: 221–241

10. Potential role of the mitochondria for the dermatological treatment of Papillon-Lefèvre

  • Authors: Castejón-Vega, B., Battino, M., Quiles, J.L., Cordero, M.D., Bullón, P.
  • Year: 2021
  • Journal: Antioxidants
  • Volume and Issue: 10(1), pp. 1–9, 95
  • Citations: 5

 

 

 

Rui Wen | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Rui Wen | Molecular Biology | Best Researcher Award

Assistant Professor Dr at Wenzhou Medical University, China

Rui Wen, an Assistant Professor at Wenzhou Medical University in China, has focused on advancing research in biomaterials, with a special interest in silk proteins for drug delivery systems. Since earning his PhD in Biomaterials from Donghua University in 2020, Rui has quickly established a reputable profile through his publications in high-impact journals and his role in editorial positions. His work encompasses essential biological processes like protein function, alternative splicing, and gene expression, with an emphasis on the use of silk-based materials for medical applications. Rui is actively involved in peer-reviewed publications, authoring eight first-author or corresponding-author articles in prominent journals over the past five years. Additionally, he has contributed to the scientific community by serving as an editorial board member and reviewer for multiple journals, illustrating his influence and expertise in the field of biomaterials.

Professional Profile

Education

Rui Wen completed his PhD in Biomaterials at Donghua University in 2020, where he focused on the biological functions of protein materials, especially silk-based biomaterials for drug delivery. His doctoral research established foundational insights into protein functionality and biomimetic applications, shaping his future focus on protein function and genetic analysis. Throughout his education, Rui developed a sophisticated understanding of biomaterials science, from molecular genetics to applications in medical technology. His PhD laid a robust academic and technical foundation, equipping him with the essential research methodologies and laboratory skills needed to contribute meaningfully to the biomaterials field. The strong academic training he received at Donghua University, combined with hands-on experience in research, has been instrumental in his transition to his current role as an Assistant Professor, where he continues to leverage his expertise in gene expression and protein function.

Professional Experience

Rui Wen’s professional journey as an Assistant Professor at Wenzhou Medical University began shortly after he completed his PhD. In this role, Rui has focused his research on developing silk-based biomaterials for medical applications, such as drug delivery. His work often involves collaborations with other experts in the biomaterials and genetic research fields, emphasizing protein functionality and biomimetic design. Rui’s academic contributions include publishing eight peer-reviewed papers as the first or corresponding author in recognized journals, including Acta Biomaterialia and the International Journal of Biological Macromolecules. These achievements highlight his commitment to advancing scientific knowledge in biomaterials. Additionally, Rui serves on editorial boards for journals like the World Journal of Biological Chemistry, further underscoring his dedication to scientific excellence and community engagement. His involvement in these roles signifies his professional growth and increasing impact within the scientific community.

Research Interests

Rui Wen’s research interests are centered on protein function, gene expression, and biomaterials, particularly focusing on the medical potential of silk-based proteins. He is intrigued by the genetic underpinnings of protein function and the application of alternative splicing in creating materials that mimic biological functions. His work has a dual focus: understanding protein behavior at a genetic level and leveraging this knowledge to develop innovative biomaterials for drug delivery. This focus on silk-based proteins, a biologically compatible and robust material, has led Rui to explore how protein sequences can be harnessed to design highly specialized biomaterials with practical medical applications. Rui’s research aims to integrate genetic insights with material science to produce versatile, biocompatible materials that can advance drug delivery and other medical therapies, contributing to new solutions in biotechnology and healthcare.

Research Skills

Rui Wen possesses extensive research skills in biomaterials science and protein analysis. His expertise includes characterizing protein functionality, analyzing gene sequences, and applying genetic engineering principles to create innovative materials. Rui has a strong background in protein biochemistry and molecular biology, which has enabled him to identify and engineer silk proteins for biomimetic applications. Additionally, he is skilled in alternative splicing and concerted evolution, both of which play a crucial role in his work with gene expression. Rui’s laboratory skills include various analytical techniques, such as protein characterization assays, molecular modeling, and genetic sequencing. His ability to publish consistently in peer-reviewed journals reflects his proficiency in scientific communication and data analysis. Furthermore, his role as a reviewer and editor highlights his critical assessment skills, making him a valuable contributor to the scientific community.

Awards and Honors

Rui Wen’s contributions to biomaterials science have been recognized through multiple awards and honors. He received funding from the China Postdoctoral Science Foundation, a competitive grant that supports emerging researchers in China. This funding enabled him to continue his exploration of silk-based proteins and their applications in drug delivery. His role on the editorial boards of respected journals like the World Journal of Biological Chemistry and Biomedical Engineering Communications is another notable achievement, reflecting the respect he has earned among his peers. In addition, his status as an invited reviewer for journals such as the International Journal of Biological Macromolecules demonstrates his expertise and the high regard of the scientific community. These honors underscore Rui’s dedication to advancing biomaterials science and highlight his influence in the fields of protein function and gene expression.

Conclusion

Rui Wen is a dedicated and promising researcher whose accomplishments in the specialized areas of protein function and biomaterials are commendable for someone early in their career. His expertise, consistent publication record, and increasing engagement with the scientific community through editorial and reviewing activities make him a competitive candidate for the Best Researcher Award. With further developments in his citation impact and expanded international collaborations, Rui Wen’s contributions are likely to gain even greater visibility and influence, establishing him as a key figure in biomaterials research.

Publications Top Notes

  1. Title: Physical Properties of the Second Type of Aciniform Spidroin (AcSp2) from Neoscona theisi Reveal a pH-Dependent Self-Assembly Repetitive Domain
    Authors: Yang, D., Wang, S., Wang, K., Zan, X., Wen, R.
    Journal: ACS Biomaterials Science and Engineering
    Year: 2023
    Volume(Issue): 9(12)
    Pages: 6670–6682
    Citations: 1
  2. Title: Complete Gene Sequence and Mechanical Property of the Fourth Type of Major Ampullate Silk Protein
    Authors: Wen, R., Wang, S., Wang, K., Zan, X., Meng, Q.
    Journal: Acta Biomaterialia
    Year: 2023
    Volume: 155
    Pages: 282–291
    Citations: 4
  3. Title: Characterization of Two Full-Length Tubuliform Silk Gene Sequences from Neoscona theisi Reveals Intragenic Concerted Evolution and Multiple Copies in Genome
    Authors: Wen, R., Wang, K., Zan, X.
    Journal: International Journal of Biological Macromolecules
    Year: 2022
    Volume: 223
    Pages: 1015–1023
    Citations: 3
  4. Title: Characterization of Two Full-Length Araneus ventricosus Major Ampullate Silk Protein Genes
    Authors: Wen, R., Yang, D., Wang, K., Zan, X.
    Journal: International Journal of Biological Macromolecules
    Year: 2022
    Volume: 213
    Pages: 297–304
  5. Title: The Novel Aciniform Silk Protein (AcSp2-v2) Reveals the Unique Repetitive Domain with High Acid and Thermal Stability and Self-Assembly Capability
    Authors: Wen, R., Wang, K., Yang, D., Zan, X., Meng, Q.
    Journal: International Journal of Biological Macromolecules
    Year: 2022
    Volume: 202
    Pages: 91–101
    Citations: 6
  6. Title: Customized Flagelliform Spidroins Form Spider Silk-Like Fibers at pH 8.0 with Outstanding Tensile Strength
    Authors: Li, X., Qi, X., Cai, Y.-M., Meng, Q., Chen, G.
    Journal: ACS Biomaterials Science and Engineering
    Year: 2022
    Volume(Issue): 8(1)
    Pages: 119–127
    Citations: 14
  7. Title: Characterization of the Second Type of Aciniform Spidroin (AcSp2) Provides New Insight into Design for Spidroin-Based Biomaterials
    Authors: Wen, R., Wang, K., Meng, Q.
    Journal: Acta Biomaterialia
    Year: 2020
    Volume: 115
    Pages: 210–219
    Citations: 16
  8. Title: Two Novel Tubuliform Silk Gene Sequences from Araneus ventricosus Provide Evidence for Multiple Loci in Genome
    Authors: Wen, R., Wang, K., Meng, Q.
    Journal: International Journal of Biological Macromolecules
    Year: 2020
    Volume: 160
    Pages: 806–813
    Citations: 10
  9. Title: Wet-Spinning Synthetic Fibers from Aggregate Glue: Aggregate Spidroin 1 (AgSp1)
    Authors: Li, X., Mi, J., Wen, R., Meng, Q., Lin, Y.
    Journal: ACS Applied Bio Materials
    Year: 2020
    Volume(Issue): 3(9)
    Pages: 5957–5965
    Citations: 10
  10. Title: Novel Highly Soluble Chimeric Recombinant Spidroins with High Yield
    Authors: Jia, Q., Wen, R., Meng, Q.
    Journal: International Journal of Molecular Sciences
    Year: 2020
    Volume(Issue): 21(18)
    Pages: 1–13, Article ID: 6905
    Citations: 11

Zhijun Tang | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Zhijun Tang | Molecular Biology | Best Researcher Award

Researcher at Shanghai Institute of Organic Chemistry, China.

Dr. Zhi-Jun Tang is an accomplished researcher at the Shanghai Institute of Organic Chemistry (SIOC) under the Chinese Academy of Sciences. With a focus on chemical biology, Dr. Tang has made significant contributions to the fields of natural product biosynthesis, synthetic biology, biocatalysis, and protein engineering. His work has led to numerous publications in prestigious journals and presentations at national and international conferences. Dr. Tang’s research is characterized by a strong emphasis on understanding the enzymatic processes involved in the biosynthesis of natural products, contributing to the development of new biocatalytic methods and expanding the potential applications of these natural compounds in various industries. As he continues to advance his research, Dr. Tang remains committed to mentoring young scientists and fostering collaborations to enhance scientific discovery.

Education

Dr. Zhi-Jun Tang obtained his Bachelor of Science degree in Chemistry from Sichuan University in July 2014. He then pursued his Ph.D. in Chemical Biology at the Shanghai Institute of Organic Chemistry (SIOC), Chinese Academy of Sciences, under the supervision of Prof. Wen Liu, graduating in July 2019. During his doctoral studies, he engaged in groundbreaking research involving the biosynthesis of natural products and the mechanisms underlying enzymatic reactions. His academic background, combined with rigorous research training, has equipped Dr. Tang with a robust foundation in chemical biology and a strong analytical skill set that supports his ongoing research endeavors in the field.

Professional Experience

Dr. Zhi-Jun Tang’s professional trajectory includes significant roles at the Shanghai Institute of Organic Chemistry (SIOC). He has served as an Associate Professor since September 2023, following a tenure as an Assistant Professor from November 2022 to August 2023. Prior to this, he worked as a Research Associate (Postdoc) under Prof. Wen Liu from July 2019 to October 2022, where he conducted pioneering research on natural product-related enzymology, biocatalysis, and fungal resistance mechanisms. His extensive experience in various research projects has enhanced his expertise in natural product synthesis and enzyme engineering. Dr. Tang has also contributed as a Graduate Research Fellow during his doctoral studies, solidifying his reputation as a skilled researcher in the academic community.

Research Interests

Dr. Zhi-Jun Tang’s research interests lie at the intersection of chemical biology and synthetic biology. He specializes in natural products biosynthesis, with a keen focus on elucidating the enzymatic mechanisms that govern the biosynthesis of bioactive compounds. His work also encompasses biocatalysis, where he explores the potential of enzymes in synthetic applications, including cycloaddition reactions and enzymatic fluorination. Furthermore, Dr. Tang investigates protein engineering, aiming to enhance enzyme efficiency and selectivity for various synthetic processes. His research not only contributes to fundamental scientific knowledge but also has practical implications for drug discovery and environmental sustainability through the development of innovative biocatalytic systems.

Research Skills

Dr. Zhi-Jun Tang possesses a diverse range of research skills essential for his work in chemical biology and enzymology. He is proficient in various experimental techniques, including enzymatic assays, molecular cloning, and biochemical characterization of natural products. Dr. Tang has extensive experience with genome mining and bioinformatics tools to identify novel biosynthetic pathways and enzyme functions. Additionally, he employs synthetic biology approaches to engineer enzymes for specific catalytic activities. His ability to integrate theoretical knowledge with practical experimentation allows him to address complex scientific questions effectively. Furthermore, Dr. Tang’s collaborative spirit and communication skills facilitate productive interactions with interdisciplinary teams, enhancing the impact of his research.

Awards and Honors

Dr. Zhi-Jun Tang has received several accolades that reflect his commitment to excellence in research. In 2023, he was appointed as a Youth Editorial Board Member of Innovation Discovery, recognizing his contributions to the scientific community. He was also awarded the prestigious College Graduate Excellence Award of Shanghai in 2019, a testament to his outstanding academic achievements during his studies. In addition, he received the Merit Student distinction from the University of Chinese Academy of Sciences in 2018, highlighting his exceptional performance as a graduate student. These awards underscore Dr. Tang’s dedication to advancing knowledge in his field and his potential for future contributions to chemical biology and related disciplines.

Conclusion

Dr. Zhi-Jun Tang exemplifies the qualities of an outstanding researcher deserving of the Best Researcher Award. His extensive knowledge in chemical biology, coupled with his innovative contributions to the fields of natural products and biocatalysis, has significantly advanced current scientific understanding. With opportunities for growth in international collaboration and mentorship, Dr. Tang is well-positioned to further influence the scientific community and drive impactful research in the future. His dedication to advancing the field, combined with his strong publication record and recognition, makes him a deserving candidate for this prestigious award.

Publications Top Notes

  • Biosynthesis of lincosamide antibiotics: reactions associated with degradation and detoxification pathways play a constructive role
    Authors: D. Zhang, Z. Tang, W. Liu
    Year: 2018
    Citations: 30
  • Black soldier fly larvae effectively degrade lincomycin from pharmaceutical industry wastes
    Authors: X. Luo, Q. Yang, Y. Lin, Z. Tang, J.K. Tomberlin, W. Liu, Y. Huang
    Year: 2022
    Citations: 29
  • Computational investigation of the mechanism of Diels–Alderase PyrI4
    Authors: Y. Zou, S. Yang, J.N. Sanders, W. Li, P. Yu, H. Wang, Z. Tang, W. Liu, K.N. Houk
    Year: 2020
    Citations: 21
  • A cyclase that catalyses competing 2+ 2 and 4+ 2 cycloadditions
    Authors: H. Wang, Y. Zou, M. Li, Z. Tang, J. Wang, Z. Tian, N. Strassner, Q. Yang, …
    Year: 2023
    Citations: 19
  • Biosynthesis of a New Fusaoctaxin Virulence Factor in Fusarium graminearum Relies on a Distinct Path To Form a Guanidinoacetyl Starter Unit Priming …
    Authors: Z. Tang, H. Tang, W. Wang, Y. Xue, D. Chen, W. Tang, W. Liu
    Year: 2021
    Citations: 14
  • Caerulomycin and collismycin antibiotics share a trans-acting flavoprotein-dependent assembly line for 2,2’-bipyridine formation
    Authors: B. Pang, R. Liao, Z. Tang, S. Guo, Z. Wu, W. Liu
    Year: 2021
    Citations: 14
  • Enzymatic [4+ 2] cycloadditions in the biosynthesis of spirotetramates and spirotetronates
    Authors: B. Pang, G. Zhong, Z. Tang, W. Liu
    Year: 2016
    Citations: 14
  • Characterization of a carboxyl methyltransferase in Fusarium graminearum provides insights into the biosynthesis of fusarin A
    Authors: Q. Yang, W. Wang, Y. Lin, Y. Lin, Z. Tang, J. Wang, J. Tao, W. Tang, W. Liu
    Year: 2021
    Citations: 9
  • Biocatalytic Fluoroalkylation Using Fluorinated S-Adenosyl-l-methionine Cofactors
    Authors: W. Ding, M. Zhou, H. Li, M. Li, Y. Qiu, Y. Yin, L. Pan, W. Yang, Y. Du, X. Zhang, …
    Year: 2023
    Citations: 5
  • Enzymatic α-Ketothioester Decarbonylation Occurs in the Assembly Line of Barbamide for Skeleton Editing
    Authors: S. Guo, Y. Sang, C. Zheng, X.S. Xue, Z. Tang, W. Liu
    Year: 2023
    Citations: 4

Elisson Romanel | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Prof Dr. Elisson Romanel | Molecular Biology | Best Researcher Award

Professor Researcher at School of Engineering of Lorena, Brazil.

Dr. Elisson Romanel is a prominent researcher and Professor of Functional Genomics and Plant Biotechnology at the School of Engineering of Lorena, University of São Paulo, Brazil. He holds a Ph.D. in Biological Sciences, with a focus on plant development and genomics, earned from the Federal University of Rio de Janeiro. His postdoctoral research included significant collaborations at renowned institutions, such as Iowa State University and the Universidad Nacional Autónoma de México. Dr. Romanel founded the Plant Genomics and Bionergy Laboratory, focusing on the genetic and metabolic pathways in sugarcane and related grasses to enhance biomass utilization in biorefineries. He has secured various grants and published extensively in respected journals, contributing valuable insights into plant genomics, flowering time regulation, and lignocellulosic metabolism. Additionally, he has supervised numerous graduate students, shaping the next generation of scientists in the field of plant biotechnology.

Profile:

Education

Dr. Elisson Romanel completed his undergraduate studies in Biological Sciences at the Federal University of Juiz de Fora in Brazil, earning his degree in 2004. He then pursued his Ph.D. at the Federal University of Rio de Janeiro, where he was awarded a sandwich Ph.D. in February 2010. During this time, he conducted research at prominent institutions, including the University of Wisconsin-Madison in the USA and the École Normale Supérieure de Lyon in France, under the supervision of Dr. Marcio Alves Ferreira. Following his Ph.D., Dr. Romanel continued his academic journey with a postdoctoral fellowship at the same university, focusing on virus, small RNAs, and transposons. His research also involved collaboration with esteemed researchers at the Universidad Nacional Autónoma de México, where he studied the Flowering Time Gene Regulatory Network. Dr. Romanel’s extensive educational background laid a solid foundation for his current role as a professor in Functional Genomics and Plant Biotechnology.

Professional Experiences 

Dr. Elisson Romanel is a distinguished researcher and educator currently serving as a Professor of Functional Genomics and Plant Biotechnology at the School of Engineering of Lorena, University of São Paulo (EEL/USP) in Brazil. He founded the Plant Genomics and Bionergy Laboratory (PGEMBL) in 2016, focusing on gene prospecting related to biomass control and lignocellulosic metabolism, particularly in sugarcane and related grasses. Dr. Romanel has conducted significant postdoctoral research at prestigious institutions, including the Federal University of Rio de Janeiro and Iowa State University, where he collaborated with renowned scientists in plant genomics and biotechnology. His work encompasses bioinformatics, gene cloning, and plant transformation, contributing to the understanding of plant development and flowering time regulatory networks. He has actively supervised several graduate students and served on editorial boards for prominent journals, further showcasing his commitment to advancing research in plant sciences and biotechnology.

Research Interests

Dr. Elisson Romanel’s research interests lie at the intersection of functional genomics and plant biotechnology, with a strong focus on the fundamental and applied aspects of plant development. His work primarily investigates gene regulatory networks and the molecular mechanisms that govern flowering time in plants such as Arabidopsis, eucalyptus, and cotton. He has extensively studied small RNAs, transposons, and the biosynthesis pathways of hemicellulose in sugarcane, aiming to enhance the utilization of plant biomass for biorefinery applications. Dr. Romanel is particularly interested in the evolutionary aspects of plant genes and their roles in lignocellulosic metabolism, contributing to sustainable agricultural practices and industrial biotechnology. Through his research at the Plant Genomics and Bionergy Laboratory (PGEMBL), he aims to uncover the genetic bases of traits that improve biomass recalcitrance and enhance bioenergy production, ultimately addressing global challenges in energy sustainability and food security.

Research skills 

Dr. Elisson Romanel possesses a diverse and comprehensive skill set in research, primarily focusing on functional genomics and plant biotechnology. His expertise includes bioinformatics, gene cloning, plant transformation, and structural and functional genomics analysis, particularly in species such as Arabidopsis, eucalyptus, and cotton. Dr. Romanel’s proficiency in transcriptome profiling and gene expression analysis allows him to investigate complex biological processes, such as flowering induction and biomass development. His ability to conduct multidisciplinary research is exemplified by collaborations with renowned laboratories and institutions worldwide, including those in the United States and Mexico. Furthermore, he has demonstrated strong leadership and mentorship skills through his supervision of numerous graduate students, guiding them in their academic and research pursuits. With a robust publication record and experience in securing research funding, Dr. Romanel effectively translates his research findings into practical applications, contributing significantly to advancements in agricultural biotechnology and plant sciences.

Award and Recognition 

Dr. Elisson Romanel is a distinguished researcher in the field of plant biotechnology and functional genomics, recognized for his significant contributions to the understanding of plant development and biomass utilization. He has secured multiple grants from esteemed funding bodies, including CAPES and FAPESP, showcasing his ability to attract substantial financial support for research initiatives. His work has led to numerous publications in reputable journals, highlighting his innovative research on gene expression and metabolic pathways in crops like sugarcane and eucalyptus. Dr. Romanel’s editorial roles on the boards of Brazilian Journal of Botany, BMC Genomics, and Frontiers in Plant Science reflect his expertise and standing in the scientific community. Furthermore, his leadership in founding the Plant Genomics and Bionergy Laboratory at the School of Engineering of Lorena, University of São Paulo, underscores his commitment to advancing research and training future scientists in the field.

Conclusion

Dr. Elisson Romanel’s comprehensive educational background, extensive research experience, leadership in establishing a laboratory, and significant contributions to plant biotechnology position him as a strong candidate for the Best Researcher Award. His ability to innovate and lead in important research areas related to plant genomics and bioenergy, combined with his dedication to mentoring the next generation of scientists, underscores his value to the scientific community. With some focus on interdisciplinary collaboration and public engagement, Dr. Romanel could further enhance his contributions to science and society.

Publication Top Notes
  1. SacEXP32 sugarcane expansin gene expression increases cell size and improves biomass digestibility
    • Authors: Mira, W., Heinz, O., Gonçalvez, A., Ferraz, A., da Franca Silva, T.
    • Year: 2024
    • Journal: Journal of Plant Biochemistry and Biotechnology
    • Volume/Issue/Page: 33(3), pp. 313–325
  2. Plant age-dependent dynamics of annatto pigment (bixin) biosynthesis in Bixa orellana
    • Authors: de Godoy Machado, K.L., Faria, D.V., Duarte, M.B.S., Otoni, W.C., Nogueira, F.T.S.
    • Year: 2024
    • Journal: Journal of Experimental Botany
    • Volume/Issue/Page: 75(5), pp. 1390–1406
  3. Advances in Tissue Culture and Transformation Studies in Non-model Species: Passiflora spp. (Passifloraceae)
    • Authors: Otoni, W.C., Soares, J.R., Souza, C.S., Nogueira, F.T.S., Silva, M.L.C.
    • Year: 2024
    • Journal: Methods in Molecular Biology
    • Volume/Issue/Page: 2827, pp. 207–222
  4. Editorial: System biology to regulatory grids: new tools and clues aimed at improving plant evolutionary-developmental (Evo-Devo) biology
    • Authors: Romanel, E., DePaoli, H.C., Brito, M.D.S.
    • Year: 2024
    • Journal: Frontiers in Plant Science
    • Volume/Issue/Page: 15, 1380569
  5. Erratum: Analysis of the PEBP gene family and identification of a novel FT orthologue in sugarcane
    • Authors: Venail, J., Da Silva Santos, P.H., Manechini, J.R., Pinto, L., Jackson, S.D.
    • Year: 2022
    • Journal: Journal of Experimental Botany
    • Volume/Issue/Page: 73(12), pp. 4266
  6. Analysis of the PEBP gene family and identification of a novel FLOWERING LOCUS T orthologue in sugarcane
    • Authors: Venail, J., Da Silva Santos, P.H., Manechini, J.R., Pinto, L., Jackson, S.D.
    • Year: 2022
    • Journal: Journal of Experimental Botany
    • Volume/Issue/Page: 73(7), pp. 2035–2049
  7. Expression of Melocactus glaucescens SERK1 sheds new light on the mechanism of areolar activation in cacti
    • Authors: Torres-Silva, G., Correia, L.N.F., Koehler, A.D., Specht, C.D., Otoni, W.C.
    • Year: 2021
    • Journal: Plant Cell, Tissue and Organ Culture
    • Volume/Issue/Page: 147(3), pp. 437–451
  8. Selection and validation of reference genes by RT-qPCR under photoperiodic induction of flowering in sugarcane (Saccharum spp.)
    • Authors: da Silva Santos, P.H., Manechini, J.R.V., Brito, M.S., Jackson, S., Pinto, L.R.
    • Year: 2021
    • Journal: Scientific Reports
    • Volume/Issue/Page: 11(1), 4589
  9. Transcriptome Analysis of Melocactus glaucescens (Cactaceae) Reveals Metabolic Changes During in vitro Shoot Organogenesis Induction
    • Authors: Torres-Silva, G., Correia, L.N.F., Batista, D.S., Specht, C.D., Otoni, W.C.
    • Year: 2021
    • Journal: Frontiers in Plant Science
    • Volume/Issue/Page: 12, 697556
  10. Transcriptomic Analysis of Changes in Gene Expression During Flowering Induction in Sugarcane Under Controlled Photoperiodic Conditions
  • Authors: Manechini, J.R.V., Santos, P.H.D.S., Romanel, E., Pinto, L.R., Vicentini, R.
  • Year: 2021
  • Journal: Frontiers in Plant Science
  • Volume/Issue/Page: 12, 635784